Immortal time may inflate the apparent disease-modifying effect of GLP-1 receptor agonists on knee osteoarthritis
Regional Anesthesia & Pain Medicine · 17.11.2026 · rapm-2026-108799
DOI: 10.1136/rapm-2026-108799 ↗Kurz gefasst
Leserbrief in der Zeitschrift Regional Anesthesia & Pain Medicine, online erschienen am 17.11.2026. Verfasst von Xianming Yao. Beteiligte Einrichtung: Chuantou Xichang Hospital, Xichang, Sichuan, China 1043663098@qq.com. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
I read with interest the study by Carter and colleagues, who used the TriNetX Global Research Network to report that glucagon-like peptide 1 receptor agonist (GLP-1 RA) use was associated with a lower cumulative incidence of total knee arthroplasty (TKA) among adults with knee osteoarthritis (OA),
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chuantou Xichang Hospital, Xichang, Sichuan, China 1043663098@qq.com.
Zitieren
APA
Yao, X. (2026). Immortal time may inflate the apparent disease-modifying effect of GLP-1 receptor agonists on knee osteoarthritis. Regional Anesthesia & Pain Medicine, rapm-2026-108799. https://doi.org/10.1136/rapm-2026-108799
Vancouver
Yao X. Immortal time may inflate the apparent disease-modifying effect of GLP-1 receptor agonists on knee osteoarthritis. Regional Anesthesia & Pain Medicine. 2026:rapm-2026-108799. doi:10.1136/rapm-2026-108799
BibTeX
@article{Yao2026,
author = {Yao, Xianming},
title = {Immortal time may inflate the apparent disease-modifying effect of GLP-1 receptor agonists on knee osteoarthritis},
journal = {Regional Anesthesia & Pain Medicine},
year = {2026},
pages = {rapm--2026--108799},
doi = {10.1136/rapm-2026-108799}
}
EUVIMED